0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Association of Changes in Vector Length with Changes in Left Ventricular Mass among Patients on Maintenance Hemodialysis : A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Visual Abstract

          Abstract

          Key Points

          • Bioimpedance has been proposed as an objective method to assess volume status among patients receiving maintenance hemodialysis.

          • The Frequent Hemodialysis Network Daily Trial measured bioimpedance parameters of volume status (vector length) and cardiac magnetic resonance imaging at baseline and 12 months.

          • We observed that changes in vector length were inversely associated with changes in left ventricular mass and volume over a 12-month period.

          Background

          Hypervolemia is thought to be a major contributor to higher left ventricular mass (LVM), a potent predictor for cardiovascular mortality among patients on maintenance hemodialysis. We hypothesized that a decrease in vector length (a bioimpedance proxy of hypervolemia) would be associated with an increase in LVM.

          Methods

          Using data from the Frequent Hemodialysis Network Daily Trial ( n=160), we used linear regression to assess the association of changes in vector length from baseline to month 12 with changes in magnetic resonance imaging measures of LVM and other cardiac parameters. We adjusted models for the randomized group, baseline vector length, age, sex, race, body mass index, vascular access, dialysis vintage, history of hypertension, heart failure, and diabetes, residual kidney function, predialysis systolic BP, ultrafiltration rate, serum-dialysate sodium gradient, hemoglobin, phosphate, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use, erythropoietin dose, and equilibrated Kt/V.

          Results

          The mean age of the patients was 50±13 years; 35% were female. In the fully adjusted models, a decline in vector length (per 50 Ω/m; i.e., increase in volume) was associated with a 6.8 g (95% confidence interval [CI], −0.1 to 13.7) and 2.6 g/m 2 (95% CI, −1.2 to 6.3) increase in LVM and LVM index, respectively, and an increase of 15.0 ml (95% CI, 7.5 to 22.4), 7.3 ml (95% CI, 3.0 to 12.7), 7.8 ml (95% CI, 3.0 to 12.7), and −0.9% (95% CI, −3.1 to 1.3) in left ventricular end-diastolic volume, left ventricular end-systolic volume, left ventricular stroke volume, and left ventricular ejection fraction, respectively. The lowest tertile of change in vector length ( i.e., greater increase in volume) was associated with greater increases in left ventricular end-diastolic volume and left ventricular stroke volume, versus the highest tertile. There was no evidence of heterogeneity by randomized group.

          Conclusions

          Change in vector length, a bioimpedance-derived proxy of volume status, was inversely associated with indices of LVM and volume measured by cardiac magnetic resonance imaging in patients randomized to conventional or frequent hemodialysis over 12 months.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: not found
          • Article: not found

          A formula to estimate the approximate surface area if height and weight be known. 1916.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

                Bookmark

                Author and article information

                Contributors
                Role: Role: Role:
                Role:
                Role:
                Role: Role: Role: Role: Role:
                Role: Role: Role: Role: Role: Role:
                Journal
                Kidney360
                Kidney360
                KIDNEY
                Kidney360
                Kidney360
                American Society of Nephrology
                2641-7650
                June 2024
                24 April 2024
                : 5
                : 6
                : 870-876
                Affiliations
                [1 ]Brigham and Women's Hospital, Boston, Massachusetts
                [2 ]Harvard Medical School, Boston, Massachusetts
                [3 ]Bayer US, LLC, Pittsburgh, Pennsylvania
                [4 ]Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
                [5 ]Departments of Medicine, Epidemiology and Population Health, and Health Policy, Stanford University School of Medicine, Stanford, California
                Author notes
                Correspondence: Dr. Finnian R. Mc Causland, email: fmccausland@ 123456bwh.harvard.edu
                Author information
                https://orcid.org/0000-0002-1040-1997
                https://orcid.org/0000-0003-1692-1851
                https://orcid.org/0000-0001-8894-0790
                https://orcid.org/0000-0002-7599-0534
                https://orcid.org/0000-0002-0299-0533
                Article
                K360-2024-000142 00013
                10.34067/KID.0000000000000443
                11219120
                38656312
                0f92e8eb-e1c4-4456-a137-bd39f75e65ef
                Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology

                This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 23 February 2024
                : 9 April 2024
                Page count
                Figures: 1, Tables: 3, References: 33, Pages: 7
                Funding
                Funded by: NIDDK
                Award ID: DK129749
                Award Recipient : Finnian R. Mc Causland
                Funded by: NIDDK
                Award ID: DK129749
                Categories
                Original Investigation
                Dialysis
                Custom metadata
                TRUE
                T
                YES

                cardiovascular,chronic hemodialysis,dialysis,heart failure,hemodialysis

                Comments

                Comment on this article